ArticleCancer biology & therapy2010

Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.

Patrick J Eulitt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.